Recent studies have suggested several possible mechanisms that may explain the resistance of cells to PI3K inhibitors, including amplification/mutation of PIK3CA and PIK3CB, loss of PTEN, and changes in tumor microenvironment. The gene discussed is PTEN; the disease is neoplasm.